These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11687689)

  • 1. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT.
    Lim HK; Choi D; Lee WJ; Kim SH; Lee SJ; Jang HJ; Lee JH; Lim JH; Choo IW
    Radiology; 2001 Nov; 221(2):447-54. PubMed ID: 11687689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
    Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
    Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results.
    Choi D; Lim HK; Kim SH; Lee WJ; Jang HJ; Lee JY; Paik SW; Koh KC; Lee JH
    Radiology; 2000 Nov; 217(2):558-63. PubMed ID: 11058660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of therapeutic response in hepatocellular carcinoma treated with percutaneous radio frequency ablation: comparison of multiphase helical computed tomography and power Doppler ultrasonography with a microbubble contrast agent.
    Choi D; Lim HK; Kim SH; Lee WJ; Jang HJ; Kim H; Lee SJ; Lim JH
    J Ultrasound Med; 2002 Apr; 21(4):391-401. PubMed ID: 11934096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multiphasic spiral computed tomography in hepatocarcinoma. An evaluation following different percutaneous ablative procedures].
    Catalano O; Esposito M; Lobianco R; Cusati B; Altei F; Siani A
    Radiol Med; 1999 Dec; 98(6):500-8. PubMed ID: 10755012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth rate of new hepatocellular carcinoma after percutaneous radiofrequency ablation: evaluation with multiphase CT.
    Park Y; Choi D; Lim HK; Rhim H; Kim YS; Kim SH; Lee WJ
    AJR Am J Roentgenol; 2008 Jul; 191(1):215-20. PubMed ID: 18562748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma treated with radio-frequency ablation: spectrum of imaging findings.
    Kim SK; Lim HK; Kim YH; Lee WJ; Lee SJ; Kim SH; Lim JH; Kim SA
    Radiographics; 2003; 23(1):107-21. PubMed ID: 12533646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidetector-row computed tomography of focal liver lesions treated by radiofrequency ablation: spectrum of findings at long-term follow-up.
    Filippone A; Iezzi R; Di Fabio F; Cianci R; Grassedonio E; Storto ML
    J Comput Assist Tomogr; 2007; 31(1):42-52. PubMed ID: 17259832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced US-guided radiofrequency ablation of hepatocellular carcinoma.
    Rajesh S; Mukund A; Arora A; Jain D; Sarin SK
    J Vasc Interv Radiol; 2013 Aug; 24(8):1235-40. PubMed ID: 23796857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central lower attenuating lesion in the ablation zone on immediate follow-up CT after percutaneous radiofrequency ablation for hepatocellular carcinoma: incidence and clinical significance.
    Park Y; Choi D; Rhim H; Kim YS; Lee JY; Chang I; Lim HK; Park CK
    Eur J Radiol; 2010 Sep; 75(3):391-6. PubMed ID: 19467813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy and safety of percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the gastrointestinal tract.
    Choi D; Lim HK; Kim MJ; Kim SH; Lee WJ; Kim SH; Lim JH; Paik SW; Koh KC; Yoo BC
    AJR Am J Roentgenol; 2004 Nov; 183(5):1417-24. PubMed ID: 15505314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Sonazoid-enhanced three-dimensional ultrasonography in the evaluation of percutaneous radiofrequency ablation of hepatocellular carcinoma.
    Luo W; Numata K; Morimoto M; Oshima T; Ueda M; Okada M; Takebayashi S; Zhou X; Tanaka K
    Eur J Radiol; 2010 Jul; 75(1):91-7. PubMed ID: 19361941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary and secondary lung malignancies treated with percutaneous radiofrequency ablation: evaluation with follow-up helical CT.
    Jin GY; Lee JM; Lee YC; Han YM; Lim YS
    AJR Am J Roentgenol; 2004 Oct; 183(4):1013-20. PubMed ID: 15385295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up.
    Dromain C; de Baere T; Elias D; Kuoch V; Ducreux M; Boige V; Petrow P; Roche A; Sigal R
    Radiology; 2002 Apr; 223(1):255-62. PubMed ID: 11930075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hepatocellular carcinoma with radiofrequency ablation: radiologic-histologic correlation during follow-up periods.
    Morimoto M; Sugimori K; Shirato K; Kokawa A; Tomita N; Saito T; Tanaka N; Nozawa A; Hara M; Sekihara H; Shimada H; Imada T; Tanaka K
    Hepatology; 2002 Jun; 35(6):1467-75. PubMed ID: 12029632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small- and medium-sized hepatocellular carcinomas: monopolar radiofrequency ablation with a multiple-electrode switching system-mid-term results.
    Woo S; Lee JM; Yoon JH; Joo I; Kim SH; Lee JY; Yoon JH; Kim YJ; Han JK; Choi BI
    Radiology; 2013 Aug; 268(2):589-600. PubMed ID: 23513241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT-guided radiofrequency ablation for hepatocellular carcinomas that were undetectable at US: therapeutic effectiveness and safety.
    Park BJ; Byun JH; Jin YH; Won HJ; Shin YM; Kim KW; Park SJ; Kim PN
    J Vasc Interv Radiol; 2009 Apr; 20(4):490-9. PubMed ID: 19328427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy.
    Choi D; Lim HK; Kim MJ; Lee SH; Kim SH; Lee WJ; Lim JH; Joh JW; Kim YI
    Radiology; 2004 Jan; 230(1):135-41. PubMed ID: 14631050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma treated with radio frequency ablation: an early evaluation with magnetic resonance imaging.
    Khankan AA; Murakami T; Onishi H; Matsushita M; Iannaccone R; Aoki Y; Tono T; Kim T; Hori M; Osuga K; Passariello R; Nakamura H
    J Magn Reson Imaging; 2008 Mar; 27(3):546-51. PubMed ID: 18183580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT.
    Meloni MF; Goldberg SN; Livraghi T; Calliada F; Ricci P; Rossi M; Pallavicini D; Campani R
    AJR Am J Roentgenol; 2001 Aug; 177(2):375-80. PubMed ID: 11461867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.